Please login to the form below

Not currently logged in
Email:
Password:

Dr Angelika Bodenteich joins Marinomed Biotechnologie

Dr Angelika Bodenteich takes up a role as head of development at the Austrian biotech company

Dr Angelika Bodenteich has been appointed head of development at Austrian company Marinomed Biotechnologie GmbH, which develops innovative therapies for respiratory diseases.

She joins from Onepharm Research & Development, where she held the positions of chief medical officer and head of development.

Prior to this she spent four years at Sanochemia Pharmazeutika as head of research & development, where she was responsible for both pharmaceutical and business development.

Dr Andreas Grassauer, CEO and co-founder of Marinomed, said: “We are delighted to welcome Angelika to the team - her scientific and professional expertise in the area of research and development as well as her experience in international collaborations and business development will certainly be a significant addition to Marinomed as we work to further develop our pipeline.”

Dr Bodenteich has more than 15 years of experience in the pharmaceutical industry and is a trained pathologist who has held positions in research and industry in Austria, Norway and the US.

3rd November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics